from the ywtn series reporting “The Tim Rats, MD,” how these two Varmints pose an immediate danger to healthcare
reported by youarewithinthenorms.com
NORMAN J CLEMENT , RPH, DDS, NORMAN L. CLEMENT PHARM-TECH, MALACHI F. MACKANDAL PHARMD, BELINDA BROWN-PARKER, IN THE SPIRIT OF JOSEPH SOLVO ESQ., INC.T. SPIRIT OF REV. IN THE SPIRIT OF WALTER R. CLEMENT BS., MS, MBA. HARVEY JENKINS MD, PH.D., DAVID STEIN, MD IN THE SPIRIT OF C.T. VIVIAN, JELANI ZIMBABWE CLEMENT, BS., MBA., IN THE SPIRIT OF THE HON. PATRICE LUMUMBA, IN THE SPIRIT OF ERLIN CLEMENT SR., EVELYN J. CLEMENT, WALTER F. WRENN III., MD., JULIE KILLINGSWORTH, RENEE BLARE, RPH, DR. TERENCE SASAKI, MD LESLY POMPY MD., CHRISTOPHER RUSSO, MD., NANCY SEEFELDT, WILLIE GUINYARD BS., JOSEPH WEBSTER MD., MBA, BEVERLY C. PRINCE MD., FACS., NEIL ARNAND, MD., RICHARD KAUL, MD., LEROY BAYLOR, JAY K. JOSHI MD., MBA, ADRIENNE EDMUNDSON, ESTER HYATT PH.D., WALTER L. SMITH BS., IN THE SPIRIT OF BRAHM FISHER ESQ., MICHELE ALEXANDER MD., CUDJOE WILDING BS, MARTIN NJOKU, BS., RPH., IN THE SPIRIT OF DEBRA LYNN SHEPHERD, BERES E. MUSCHETT, STRATEGIC ADVISORS
DEFENSE ATTORNEY RON ALD CHAPMAN OUTLINES, “HOW WE GOT HERE ??”
SENZENI NA?
RISE OF THE SUBJECT MATER COCK SUCKERS
“The discipline of pain medicine is an accepted and recognized medical subspecialty
…Legitimate and qualified medical experts have specialized knowledge, education, training, and experience and utilize a multi-disciplinary approach
… Fellowship training programs exist for the purpose of further education in the subspecialty of pain medicine, making graduates eligible for board certification in pain medicine.”
…is recognized by state regulatory boards as a subspecialty of anesthesiology, physical medicine and rehabilitation, neurology, and psychiatry, which are recognized as primary specialties
WAR ON YOUR DOCTOR

However, the prosecutors have retained these so called experts listed below, Munzing, Sullivan, Patel et. al, because they are more than willing to say whatever was needed as long as they are paid millions of dollars on their biased and prejudicials testimonies.
FEDERAL COURT DETERMINES DR. TIMOTHY MUNZING’S (SMCS) TESTIMONY NOT CREDIBLE

I. BACKGROUND
Case No. 2:19-cr-202 Judge Michael H. Watson: Defendant Dr. Thomas J Romano was charged with thirty-four counts of unlawfully distributing a controlled substance. See Superseding Indictment, ECF No. 30. From August 1 through August 12, 2022. The Court presided over the Defendant’s trial. See ECF Nos. 72, 75, 77, 78-83, & 86. The Jury returned a verdict of acquittal as to ten counts and a guilty verdict as to the other counts. See ECF No. 87.

While the jury was deliberating, the Defendant moved to dismiss the indictment based on newly disclosed impeachment material on one of the government, Dr.Timothy Munzing(“Dr.Munzing”)

That summary strongly suggested that Dr. Munzing’s DEA Hearing testimony undermined or contradicted some of his central points on the stand in this case. See id. At 11-17. A subsequent review of the DEA Hearing Transcript confirmed that, at the DEA Hearing, Dr. Munzing gave contradictory testimony to the testimony he offered in this trial.



UNDERSTANDING RUAN/KHAN
According to Walter F. Wrenn, MD
” Have we come to a time in medicine when we care nothing about the welfare of patients seeking care and refusing those on controlled medications that assist them in carrying out their activities of daily living? What has fostered this attitude?
Could it be that due to the hysteria and unfounded charges, and imprisonment of physicians who prescribe opiate pain medications and have been blamed unfairly for opiate addiction and increased death?

Opiate addiction is not caused by physicians who prescribe opiate pain medications or by pharmaceutical companies that make opiate pain medication. It is caused entirely and solely by how the opiate medications work in the body. This medication attaches to opiate receptors in the brain and body and is detoxified by the liver.
This process has nothing to do with the milligram (MME) dose or whether it is a short-acting or long-acting medication. It is the physiology of all opiate medications, legal or illegal. An environment has been created where proper care and treatment have been threatened.”
Ruan/Khnan from the United States Supreme Court

” In the practice of medicine, good faith means the honest exercise of good professional judgment as to a patient’s medical needs. Good faith connotes a honest effort to treat patients in compliance with generally-recognized and acceptable standards of medical practice.

The unanimous decision in Ruan/Khnan from the United States Supreme Court dismantles a corrupt system led by DOJ/DEA that has scapegoated doctors for an opiate crisis for which they are not responsible.
No more will mere negligence be morphed into drug trafficking by federal prosecutors who want to appear to be fighting the opiate crisis while actually punishing chronic pain patients who need their doctors.”
RUSSO’S NOTES FROM THE BOTHRA TRIAL, DETROIT, MICHIGAN


https://www.c-span.org/video/?418535-1/opioid-epidemic
“…PROP still claims that the CDC “has been clear about the cause of the crisis: overprescribing of opioids, especially for chronic non-cancer pain…”
SENZENI NA??

DR. TIMOTHY KING, MD, THE KING OF PERJURY AND DECEPTIONS
Dr. Timothy King is a so-called government expert on opioids and pain management. However, allegations have emerged accusing Dr. King of providing false expert testimony and biased opinions that have destroyed the lives of thousands of healthcare professionals.

Dr. King, a physician who has risen to notoriety as a government expert, has been accused of perpetuating a web of deception that has led to the unjust incarceration and devastation of countless innocent healthcare professionals.
One of the core contentions against Dr. King’s testimonies is his insistence on the need for “objective evidence” of functional improvement for legitimate opioid prescriptions. However, the nature of pain is subjective, making it challenging to quantify and assess it objectively. Dr. King’s failure to provide scientific evidence to support his claim raises questions about the validity of his expert opinions.
DR. ANDREW KOLODNY, MD THE FATHER OF MODERN-DAY PAIN “EUGENICS”
Who is PROP?
Announced its founding and mission in a 2011 article in Annals of Internal Medicine (Van Korff was the lead author; co-authors included Andrew Kolodny and Roger Chou )
• Described PROP as a “nonprofit organization with no pharmaceutical industry funding or ties” that would “identify practical approaches to more cautious opioid prescribing in community practice.”
• Declared that “guidelines for long-term opioid therapy should not be developed by the field of pain medicine alone. Rather, experts from general medicine, addiction medicine, and pain medicine should jointly reconsider how to increase the margin of safety.”
However, “Kolodny has drawn the ire of many pain patients,” stating Pat Anson’s December 5, 2020 article in the Pain News Network,
“… they blamed him for their increased suffering, loss of access to opioids, and anecdotal evidence of a rising number of suicides in the pain community. A small group of patient advocates staged a “Killer Kolodny Rally” outside Brandeis University, where he co-directs opioid research at the Heller School for Policy and Management.
PROP still claims that the CDC “has been clear about the cause of the crisis: overprescribing of opioids, especially for chronic non-cancer pain.”
Father of modern-day pain eugenics
https://www.c-span.org/video/?418535-1/opioid-epidemic
Dr. Kolodny, MD is the Father of Modern Day Pain Eugenics who is on record in the NewYork Times, by Austin Frakt and Toni Monkovic, published Nov. 25, 2019, updated Dec. 2, 2019, called:
THE NEW HEALTH CARE, “A ‘Rare Case Where Racial Biases’ Protected African-Americans,”
Kolodny states;
“Fewer opioid prescriptions meant fewer deaths (possibly 14,000), but the episode also reveals how prevalent and harmful stereotypes can be, even if implicit.”
https://www.c-span.org/video/?418535-1/opioid-epidemic
When the opioid crisis began to escalate some 20 years ago, many African Americans had a layer of protection against it. But that protection didn’t come from the effectiveness of the American medical system. Instead, researchers believe, it came from racial stereotypes embedded within that system.

As unlikely as it may seem, these negative stereotypes appear to have shielded many African Americans from fatal prescription opioid overdoses. This is not a new finding. But for the first time, analysis has put a number behind it, projecting that around 14,000 black Americans would have died if their mortality rates related to prescription opioids had been equivalent to that of white Americans.
A fourth possibility is that some white doctors were more empathetic to the pain of people who were like them and less empathetic to those who weren’t. Some of this bias “can be unconscious,” said Dr. Andrew Kolodny, a director of opioid policy research at Brandeis University.

This accidental benefit for African Americans is far outweighed by the long history of harm they have endured from inferior health care, including infamous episodes like the Tuskegee study. And it doesn’t remedy the way damaging stereotypes continue to influence aspects of medical practice today. “The reason to study this further is twofold,” Dr. Kolodny said. “It’s easy to imagine the harm that could come to blacks in the future, and we need to know what went wrong with whites and how they were left exposed” to overprescribing.”
DOJ/DEA ADOPTING AND PROMOTING EUGENICS (NEO)
https://www.c-span.org/video/?418535-1/opioid-epidemic
FOLLOWING THE KOLODNY MONEY TRAIN
Many pain patients believe Kolodny has enriched himself by promoting the use of Suboxone, an addiction treatment drug. It has been reported. Kolodny made substantial money as a consultant and expert witness for law firms involved in opioid litigations.
During Oklahoma’s lawsuit against Johnson & Johnson, Kolodny testified that he was being paid $725 an hour and would collect up to $500,000 for his services in that trial alone.
Kolodny has not always been upfront about who is paying him. In he revised his conflict of interest statements in two medical journal articles to include his work in malpractice lawsuits. The articles were co-authored with former CDC director Thomas Frieden.
That unproven allegation led Kolodny to ask for and receive a letter from Indivior, Suboxone’s manufacturer, stating that he has no financial interest in the company.
CHAD KOLLAS, MD, ON DEBUNKING ANDREW KOLODNEY, MD, AND PROP

CDC: “24-126 million Americans in chronic pain” “Restore the sacred physician-patient relationship. “
According to Salley Satel, MD,

The consequences of this new OPIOPHOBIA have fallen on the shoulders of patients experiencing acute or chronic pain, many of whom have found themselves abandoned by healthcare providers in the name of preventing opioid abuse and addiction.
Dose tapering of chronic-pain patients with commercial health insurance and Medicare Advantage has increased substantially in recent years, and a quarter of those patients have had their doses tapered more quickly than medically recommended, according to a 2019 study by researchers at the University of California, Davis.
In 2017, a survey of 3,100 chronic pain patients by the non-profit Pain News Network revealed that 71% could no longer obtain necessary opioid medication from a doctor or had to settle for a lower dose.
RICHARD LAWHERN, PHD, DEBUNKING CDC’S ENTIRE OPIOID GUIDELINES 2016 AND 2022

“..It has long been known that there is a wide range in minimum effective opioid doses between individuals. But none of the clinical trials literature for opioid analgesics — and specifically none of the trials reviewed by the Agency for Healthcare Research and Quality — employs protocols that address this variability.
PROP still claims that the CDC “has been clear about the cause of the crisis: overprescribing of opioids, especially for chronic non-cancer pain…”
Thus, both the revised CDC guidelines and the final report of the Opioid Workgroup chose to ignore 25-year clinical literature identifying genetic influences on variations in opioid metabolism between individuals. Minimum effective opioid dose and side effects are mediated by polymorphism of CYP450 enzymes in the human liver.
As a consequence, the entire clinical trial literature on the effectiveness and safety of prescription opioid analgesics is arguably in need of being burned to the ground and done over. This is one of the larger “dirty little secrets” of current clinical practice in pain management.
I have come to believe that revised CDC guidelines were published with the full awareness of the writers that if these two issues were ever acknowledged, the CDC would be forced to suspend publication and repudiate their advocacy for restricting patient access to this indispensable class of medications.
Instead, CDC chose to “damn the torpedoes and full speed ahead” with published public health policy that is now confirmed as clinically unsafe and deeply ethically flawed…”
SENZENI NA ??
FOR NOW, YOU ARE WITHIN
THE NORMS
OR SEND
$175.00 OR MORE TO CASH APP:$docnorm
ZELLE 3135103378
So, Donate to the “Pharmacist For Healthcare Legal Defense Fund,”
Who is Russo? It appears he is an important ally for our ranks.
Dr Gharibo is another hit man out of NYU that DOJ uses. He was allowed to make a kill shot against me by my incompetent lawyer, Michael Khouri.